Syngenta AG is a global company that produces agrochemicals and seeds and is based in Basel, Switzerland. As a biotechnology company, it conducts genomic research. It was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. As of 2014 Syngenta is the world’s largest crop chemical producer As of 2009 it ranked third in seeds and biotechnology sales. Sales in 2015 were approximately US$13.4 billion, over half of which were in emerging markets. It is owned by ChemChina, a Chinese state-owned enterprise.

Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Trimaran SA designs and develops multimedia applications for web sites for television graphic presentations. The firm develops 3D computer graphics programs. It specializes in 3D graphics & special effects for advertising and television and web site projects (creation, complex structuring, revitalization, maintenance). The company was founded by Olivier Emery in January 1991, the company is headquartered in Vanves, France.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Avigen, Inc., a biopharmaceutical company, engages in identifying and developing products to treat patients with neurological and other disorders. The company develops the AV411 portfolio, which includes the phase II-stage lead drug compound and proprietary analogs and represents novel, non-opioid drugs for the treatment of various large pain and drug addiction indications. AV411 is an orally bioavailable small molecule; a glial attenuator that suppresses pro-inflammatory cytokines IL-1 beta, TNF alpha, and IL-6; and a toll-like receptor 4 (TLR4) functional antagonist that may contribute to its attenuation of neuroinflammation. AV411 is being evaluated in Phase Ib/IIa clinical trials. The company was founded in 1992 and is headquartered in Alameda, California. As of December 18, 2009, Avigen, Inc. operates as a subsidiary of MediciNova Inc

Kukje Pharma is a pharmaceutical manufacturing company. They offer medical technology for ophthalmic diseases, which include macular degeneration and glaucoma. It delivers pharmaceutical products to domestic and international markets. Their product line is equipped with modern technology, such as a high-quality lyophilizer for producing cephalosporin medicines.

Nanjing Heron Pharmaceutical Science & Technology Co., Ltd. principally engages in the research, development, production, and sale of drugs. The company was founded by Yang Chao on March 12, 2013 and is headquartered in Nanjing, China.

Hunan Nanguo Yaodu Traditional Chinese Medicine Co., Ltd., established on 2011-12-05, Business scope includes licensed projects:Drug Wholesale;pharmaceutical production;Health food production;Pharmaceutical commissioned production;Chinese Herbal Pieces Decoction Service;Drug import and export;Drug internet information service;road freight transport(Does not contain dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Chinese herbal extracts;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Healthy food(prepackaged)Sales;Chinese herbal medicine planting;Chinese herbal medicine acquisition;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);internet sales(Except for products that require a license for sale);Primary processing of edible agricultural products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

National Hospital Organization is an independent administrative agency under the umbrella of Ministry of Health, Labour, and Welfare of Japan that operates medical institutions. It provides medical and healthcare services. The firm also offers medical research and development, and healthcare engineers and medical technicians training. The organization was founded on April 4, 2004 and is headquartered in Tokyo, Japan.

B·R·A·H·M·S explores, develops and produces new diagnostic test procedures to improve the diagnosis, and thereby the treatment, of life-threatening illnesses. This takes place with over 400 employees, on the basis of their own patented biomarkers, and leads to medically and economically superior diagnostic insights for patients and medical professionals. B·R·A·H·M·S products reach customers in over 65 countries around the world and are leaders in their specialized markets.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Peking University Shenzhen Hospital is a private company headquartered in Guangdong, China. The firm operates hospitals.

Shanghai Pinshan Pharmaceutical Consulting Co., Ltd., established on 2017-08-11, Business scope includes licensed projects:food business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in medical consultation,medical technology,Information Technology,Internet technology,electronic technology,Technical consulting in the field of medical science and technology,Technical Services,technology development,technology transfer,Information Consulting Service(Not including licensing information consulting services),Socioeconomic Advisory Services,marketing planning,Corporate Image Planning,Conference and Exhibition Services,sell cosmetics,Daily necessities,handcrafted gift(Except for ivory and its products),Class I medical device,Class II medical device.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. MediciNova’s pipeline includes clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers